Randomized phase II trial of carboplatin + nab-paclitaxel versus cisplatin + gemcitabine for chemotherapy-naïve squamous cell carcinoma: North Japan lung cancer study group 1302.

Yosuke KawashimaToshiyuki HaradaYuka FujitaTaku NakagawaKana WatanabeNaoto MorikawaKei TakamuraKenya KanazawaTomoya KudaKazuhiro UsuiAkimasa SekineAkira InoueShunichi Sugawara

Published in: International journal of clinical oncology (2020)

CnP had similar response as CG despite being a carboplatin-based regimen and toxicities differed between arms. Regarding ORR, CnP was comparable to CG for SQ.

Keyphrases

locally advanced
squamous cell carcinoma
phase ii study
phase iii
open label
placebo controlled
double blind
clinical trial
rectal cancer
phase ii
lymph node metastasis
advanced non small cell lung cancer
tertiary care
epidermal growth factor receptor
chemotherapy induced